191 related articles for article (PubMed ID: 26824196)
1. Prognostic implications of resection extent for patients with glioblastoma multiforme: a meta-analysis.
Li XZ; Li YB; Cao Y; Li PL; Liang B; Sun JD; Feng ES
J Neurosurg Sci; 2017 Dec; 61(6):631-639. PubMed ID: 26824196
[TBL] [Abstract][Full Text] [Related]
2. The influence of maximum safe resection of glioblastoma on survival in 1229 patients: Can we do better than gross-total resection?
Li YM; Suki D; Hess K; Sawaya R
J Neurosurg; 2016 Apr; 124(4):977-88. PubMed ID: 26495941
[TBL] [Abstract][Full Text] [Related]
3. Maximize surgical resection beyond contrast-enhancing boundaries in newly diagnosed glioblastoma multiforme: is it useful and safe? A single institution retrospective experience.
Pessina F; Navarria P; Cozzi L; Ascolese AM; Simonelli M; Santoro A; Clerici E; Rossi M; Scorsetti M; Bello L
J Neurooncol; 2017 Oct; 135(1):129-139. PubMed ID: 28689368
[TBL] [Abstract][Full Text] [Related]
4. Role of surgical resection in recurrent glioblastoma: prognostic factors and outcome evaluation in an observational study.
Pessina F; Navarria P; Cozzi L; Tomatis S; Riva M; Ascolese AM; Santoro A; Simonelli M; Bello L; Scorsetti M
J Neurooncol; 2017 Jan; 131(2):377-384. PubMed ID: 27826681
[TBL] [Abstract][Full Text] [Related]
5. Maximizing the extent of resection and survival benefit of patients in glioblastoma surgery: high-field iMRI versus conventional and 5-ALA-assisted surgery.
Roder C; Bisdas S; Ebner FH; Honegger J; Naegele T; Ernemann U; Tatagiba M
Eur J Surg Oncol; 2014 Mar; 40(3):297-304. PubMed ID: 24411704
[TBL] [Abstract][Full Text] [Related]
6. Role of Intra-operative MRI (iMRI) in Improving Extent of Resection and Survival in Patients with Glioblastoma Multiforme.
Khan I; Waqas M; Shamim MS
J Pak Med Assoc; 2017 Jul; 67(7):1121-1123. PubMed ID: 28770902
[TBL] [Abstract][Full Text] [Related]
7. Impact of intraoperative MRI-guided resection on resection and survival in patient with gliomas: a meta-analysis.
Li P; Qian R; Niu C; Fu X
Curr Med Res Opin; 2017 Apr; 33(4):621-630. PubMed ID: 28008781
[TBL] [Abstract][Full Text] [Related]
8. Influence of iMRI-guidance on the extent of resection and survival of patients with glioblastoma multiforme.
Senft C; Franz K; Blasel S; Oszvald A; Rathert J; Seifert V; Gasser T
Technol Cancer Res Treat; 2010 Aug; 9(4):339-46. PubMed ID: 20626200
[TBL] [Abstract][Full Text] [Related]
9. Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.
Niranjan A; Kano H; Iyer A; Kondziolka D; Flickinger JC; Lunsford LD
J Neurosurg; 2015 Apr; 122(4):757-65. PubMed ID: 25594327
[TBL] [Abstract][Full Text] [Related]
10. Current neurosurgical management and the impact of the extent of resection in the treatment of malignant gliomas of childhood: a report of the Children's Cancer Group trial no. CCG-945.
Wisoff JH; Boyett JM; Berger MS; Brant C; Li H; Yates AJ; McGuire-Cullen P; Turski PA; Sutton LN; Allen JC; Packer RJ; Finlay JL
J Neurosurg; 1998 Jul; 89(1):52-9. PubMed ID: 9647172
[TBL] [Abstract][Full Text] [Related]
11. The impact of sequential vs. combined radiochemotherapy with temozolomide, resection and MGMT promoter hypermethylation on survival of patients with primary glioblastoma--a single centre retrospective study.
Rapp M; Goeppert M; Felsberg J; Steiger HJ; Sabel M
Br J Neurosurg; 2013 Aug; 27(4):430-5. PubMed ID: 23418781
[TBL] [Abstract][Full Text] [Related]
12. Surgery for Glioblastoma: Impact of the Combined Use of 5-Aminolevulinic Acid and Intraoperative MRI on Extent of Resection and Survival.
Coburger J; Hagel V; Wirtz CR; König R
PLoS One; 2015; 10(6):e0131872. PubMed ID: 26115409
[TBL] [Abstract][Full Text] [Related]
13. Combined modality treatment of newly diagnosed glioblastoma multiforme in a regional neurosurgical centre.
Gauden AJ; Hunn A; Erasmus A; Waites P; Dubey A; Gauden SJ
J Clin Neurosci; 2009 Sep; 16(9):1174-9. PubMed ID: 19540125
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of Reintervention in Recurrent Glioblastoma: An Indispensable Weapon for Increasing Survival.
Delgado-Fernandez J; Garcia-Pallero MÁ; Blasco G; Penanes JR; Gil-Simoes R; Pulido P; Sola RG
World Neurosurg; 2017 Dec; 108():610-617. PubMed ID: 28939537
[TBL] [Abstract][Full Text] [Related]
15. The influence of intraoperative resection control modalities on survival following gross total resection of glioblastoma.
Neidert MC; Hostettler IC; Burkhardt JK; Mohme M; Held U; Kofmehl R; Eisele G; Woernle CM; Regli L; Bozinov O
Neurosurg Rev; 2016 Jul; 39(3):401-9. PubMed ID: 26860420
[TBL] [Abstract][Full Text] [Related]
16. Impact of extent of resection and recurrent surgery on clinical outcome and overall survival in a consecutive series of 170 patients for glioblastoma in intraoperative high field magnetic resonance imaging.
Coburger J; Wirtz CR; König RW
J Neurosurg Sci; 2017 Jun; 61(3):233-244. PubMed ID: 26149222
[TBL] [Abstract][Full Text] [Related]
17. Association of the Extent of Resection With Survival in Glioblastoma: A Systematic Review and Meta-analysis.
Brown TJ; Brennan MC; Li M; Church EW; Brandmeir NJ; Rakszawski KL; Patel AS; Rizk EB; Suki D; Sawaya R; Glantz M
JAMA Oncol; 2016 Nov; 2(11):1460-1469. PubMed ID: 27310651
[TBL] [Abstract][Full Text] [Related]
18. Patient-Specific Resection Strategy of Glioblastoma Multiforme: Choice Based on a Preoperative Scoring Scale.
Jiang H; Cui Y; Liu X; Ren X; Lin S
Ann Surg Oncol; 2017 Jul; 24(7):2006-2014. PubMed ID: 28321691
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Implications of Extent of Resection in Glioblastoma: Analysis from a Large Database.
Trifiletti DM; Alonso C; Grover S; Fadul CE; Sheehan JP; Showalter TN
World Neurosurg; 2017 Jul; 103():330-340. PubMed ID: 28427986
[TBL] [Abstract][Full Text] [Related]
20. Complete resection of contrast-enhancing tumor volume is associated with improved survival in recurrent glioblastoma-results from the DIRECTOR trial.
Suchorska B; Weller M; Tabatabai G; Senft C; Hau P; Sabel MC; Herrlinger U; Ketter R; Schlegel U; Marosi C; Reifenberger G; Wick W; Tonn JC; Wirsching HG
Neuro Oncol; 2016 Apr; 18(4):549-56. PubMed ID: 26823503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
